[go: up one dir, main page]

AU6128398A - New composition - Google Patents

New composition

Info

Publication number
AU6128398A
AU6128398A AU61283/98A AU6128398A AU6128398A AU 6128398 A AU6128398 A AU 6128398A AU 61283/98 A AU61283/98 A AU 61283/98A AU 6128398 A AU6128398 A AU 6128398A AU 6128398 A AU6128398 A AU 6128398A
Authority
AU
Australia
Prior art keywords
new composition
composition
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61283/98A
Inventor
Kjell Alving
Jan M. Lundberg
Jon Lundberg
Eddie Weitzberg
Peter Wiklund
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NITRICARE KB
Original Assignee
NITRICARE KB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NITRICARE KB filed Critical NITRICARE KB
Publication of AU6128398A publication Critical patent/AU6128398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/02Ammonia; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU61283/98A 1997-02-21 1998-02-20 New composition Abandoned AU6128398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9700617A SE9700617D0 (en) 1997-02-21 1997-02-21 New composition
SE9700617 1997-04-22
PCT/SE1998/000301 WO1998047495A1 (en) 1997-02-21 1998-02-20 New composition

Publications (1)

Publication Number Publication Date
AU6128398A true AU6128398A (en) 1998-11-13

Family

ID=20405878

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61283/98A Abandoned AU6128398A (en) 1997-02-21 1998-02-20 New composition

Country Status (3)

Country Link
AU (1) AU6128398A (en)
SE (1) SE9700617D0 (en)
WO (1) WO1998047495A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103275A (en) * 1998-06-10 2000-08-15 Nitric Oxide Solutions Systems and methods for topical treatment with nitric oxide
EP1303286B1 (en) * 2000-07-11 2006-04-26 Bayer HealthCare AG Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
GB0021317D0 (en) 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2047878A1 (en) * 1969-06-13 1971-03-19 Chanteaud Laboratoires Treatment of pheasants using arginine, - ascorbic acid and mineral salts
FR2459047A1 (en) * 1979-06-19 1981-01-09 Begouen Jean Paul VETERINARY NITRATE MEDICINE FOR THE TREATMENT OF YOUNG CALVES DIARRHEA
CH629100A5 (en) * 1979-09-27 1982-04-15 Solco Basel Ag Hautpraeparat.
NL8401782A (en) * 1984-06-04 1986-01-02 Jan Willem Bins THERAPEUTIC PREPARATION WITH AMMONIUM NITRATE AS AN ACTIVE SUBSTANCE.
DD281543A5 (en) * 1988-06-17 1990-08-15 Univ Leipzig METHOD OF MANUFACTURING A MEANS FOR IMPROVING MUSCULAR AEROBIC PERFORMANCE, ESPECIALLY IN TRAINING AND COMPETITION EXPOSURES
PL180769B1 (en) * 1994-02-21 2001-04-30 Univ Aberdeen Acidified nitrite as an agent against micro-organisms

Also Published As

Publication number Publication date
WO1998047495A1 (en) 1998-10-29
SE9700617D0 (en) 1997-02-21

Similar Documents

Publication Publication Date Title
AU5335798A (en) Stomatic composition
AU8747498A (en) Food-preservative composition
AU9066598A (en) Substituted 4-benzoyl-pyrazoles
EP1002847B8 (en) Self-adhesive composition
AU5575398A (en) Hairdye compositions
AU8121998A (en) Composition
AU1098499A (en) Emulsifier-lipid composition
AU1873299A (en) Deodorant composition
AU6090898A (en) Substituted 4-benzoyl-pyrazoles
AUPP053197A0 (en) Compositions
AU6128398A (en) New composition
AU2648899A (en) Composition
AU7530198A (en) Substituted 4-benzoyl-pyrazoles
AU5391798A (en) Thiamacrolides
AU7212698A (en) Substituted aryluracils
AU7677998A (en) Powder-paint binder composition
AUPO854397A0 (en) Composition
AU6237398A (en) N-het-substituted glycerophosphoethanolamines
AU7208798A (en) 1-cyano-2-alkylthio-2-arylthioethenes
AU7780498A (en) Cafetiere
AUPO408696A0 (en) Berley composition
AUPO371396A0 (en) Composition
AUPO157796A0 (en) Composition
AUPP531198A0 (en) Composition
HK1037486A (en) Composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase